All lobbying filings

DLA Piper LLP (US)

DLA Piper LLP (US) filed a Q1 report for Currax Pharmaceuticals LLC on April 21, 2025, reporting $60,000 in lobbying income.

Lobbying for Currax Pharmaceuticals LLC · Specialty pharmaceutical business

As filed: DLA PIPER LLP (US) for CURRAX PHARMACEUTICALS LLC.

All filings by DLA Piper LLP (US) · Everything Currax Pharmaceuticals LLC has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$60,000

What the client paid this registrant for the period.

Client based in

Tennessee

Official filing document

Lobbyists on this filing 1

MARGARET MARTIN New on this filing

Previously held: Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard Burr

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Legislative and regulatory policies and proposals related to obesity treatment. Article 20 pharmacovigilance proceedings before the European Commission.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.